Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
ADVL 1615: A phase 1 Study of Pevonedistat (MLN4924), A Cullin Ligase Inhibitor, In Combination with Temozolomide and Irinotecan in Pediatric Patients with Recurrent or Refactory Solid Tumors
Grant
Overview
Affiliation
Overview
Date/time Interval
June 27, 2018 - June 28, 2018
Awarded By
CHILDREN'S HOSPITAL (PHILADELPHIA)
Total Award Amount
0.00
Direct Costs
0.00
Sponsor Award Id
Affiliation
Contributor
Ana Galtarossa Xavier
Investigator
Elizabeth Alva
Investigator
Gregory Friedman M.D.
Investigator
Kimberly Whelan M.D.
Investigator
Wayne Liang
Investigator